Cinclus i Media | Vetenskapliga artiklar | Cinclus Pharma

Vår forskning

Vetenskapliga artiklar

Vetenskapliga publikationer relaterade till Cinclus Pharmas forskning och utveckling.

2025

Optimised biopharmaceutical and pharmacokinetic properties of a Linaprazan glurate tablet formulation to be used in phase 3

Poster presentation, UEG Journal

Clinical Trial - Dose-Finding Study of Linaprazan Glurate, A Novel Potassium-Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis

Published article in Alimentary Pharmacology and Theraputics

Optimised biopharmaceutical and pharmacokinetic properties of a linaprazan glurate tablet formulation to be used in phase 3

Poster presentation, Gastroenterology

Pharmacokinetics and pharmacodynamics of linaprazan glurate after multiple oral doses up to 14 days in healthy subjects

Poster presentation, Gastroenterology

Pharmacokinetics and pharmacodynamics of linaprazan glurate after Multiple oral doses up to 14 days in healthy subjects

Oral presentation, UEG Journal

Pharmacokinetics and pharmacodynamics of linaprazan glurate aftermultiple oral doses up to 14 days in healthy subjects

Poster presentation, Gastroenterology

Linaprazan glurate is highly effective in treating moderate to severe Erosive esophagitis- a double-blind, randomized, dose finding study

Moderated poster, UEG Journal

Linaprazan glurate is well tolerated in the treatment of patients with Erosive esophagitis- a double-blind, randomized, dose finding study

Oral presentation, UEG Journal

Linaprazan glurate is highly effective in treating moderate to severe erosive esophagitis- a double-blind, randomized, dose finding study

Oral presentation, Gastroenterology